Hemophilia Clinical and Collaborative Care Recommendations for Cost Savings in a Managed Care Setting
Track 1: Clinical Updates and Treatment Management Recommendations
Track 2: Collaborative and Comprehensive Care Recommendations

• Release date: December 7, 2015
• Expiration date: June 30, 2017
• Estimated Time to Complete Activity: 1.5 hours
• Compatible with all modern browsers and mobile devices

Distinguished Multi-disciplinary Faculty Presenters

Joan Couden, BSN, RN National Director, Bleeding Disorder Program Walgreens Infusion Services, Hemophilia Click here for biography

Jennifer Maahs, RN, PNP, MSN Nurse Practitioner Indiana Hemophilia and Thrombosis Center Indianapolis, IN Click here for biography Vanita Pindolia, PharmD, BCPS Vice President, Ambulatory Clinical Pharmacy Programs Henry Ford Health System/Health Alliance Plan of Michigan Click here for biography Celynda G. Tadlock, PharmD, MBA Vice President, Pharmacy Business Development Aetna Click here for biography Michael Tarantino, MD Professor of Pediatrics Division of Pediatric Hematology/Oncology University of Illinois College of Medicine Medical Director Bleeding & Clotting Disorders Institute Click here for biography

Target Audience

• Medical Directors, Pharmacy Directors, specialty pharmacists, and clinical pharmacists from health plans, HMOs, pharmacy benefit managers (PBMs), specialty pharmacy providers (SPPs), integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
• Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for hemophilia patients including: physicians, pharmacists, nurses, case managers, and social workers

Program Overview
Due to the advent of new and more costly treatment modalities, the management of pediatric and adult hemophilia patients has become more complicated for physicians, nurses, case managers, payers, specialty pharmacies, home health providers and family/caregivers. In the absence of a coordinated educational effort, the full benefits of care coordination have not yet been achieved.  This educational initiative will provide managed care professionals with the latest information, presented by multi-disciplinary expert faculty, on the management of pediatric and adult hemophilia patients in health plan and other managed care settings. The hemophilia comprehensive care team is represented on the faculty panel, including Hemophilia Treatment Center (HTC) Medical Directors, HTC Nurse Coordinators, Managed Care Executives, and Specialty Pharmacy and Home Infusion Providers.

Educational Objectives
After completing this activity, the participant should be better able to:

• Describe the effects of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes
• Evaluate current and emerging hemophilia therapies for children and adults, with and without inhibitors
• Employ a collaborative and comprehensive care model, including partnering HTCs, to optimize clinical and economic outcomes for health plan patients with hemophilia
• Recommend hemophilia management policies and protocols to optimize patient outcomes in a managed care and/or specialty pharmacy setting

Accreditation Statements

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements  and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources (MER), National Hemophilia Foundation, and Impact Education, LLC.  MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources designates this enduring web activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Track 1: Clinical Updates and Treatment Management Recommendations —1.5 CME Credits
• Track 2: Collaborative and Comprehensive Care Recommendations —1.5 CME Credits

Pharmacy Credit

	Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

• Track 1: Clinical Updates and Treatment Management Recommendations —1.5 contact hours, Universal Activity Number – 0816-9999-15-040-H01-P
• Track 2: Collaborative and Comprehensive Care Recommendations —1.5 contact hours, Universal Activity Number – 0816-9999-15-041-H01-P

This activity is certified as Knowledge-based CPE.

Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This CE activity provides 1.5 contact hours of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.

• Track 1: Clinical Updates and Treatment Management Recommendations —1.5 contact hours
• Track 2: Collaborative and Comprehensive Care Recommendations —1.5 contact hours

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the National Hemophilia Foundation, Impact Education, LLC, and/or Novo Nordisk, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, the National Hemophilia Foundation, Impact Education, LLC, and/or Novo Nordisk, Inc. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period December 7, 2015 through June 30, 2017, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.